DOCSLIB.ORG

General Thoracic Crosswalk ICD-9 to ICD-10

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
General Thoracic Crosswalk ICD-9 to ICD-10 General Thoracic Surgery ICD9 to ICD10 Crosswalks ICD-9 Code ICD-9 Description ICD-10 Code ICD-10 Description 150.3 Malignant neoplasm of upper third of esophagus C15.3 Malignant neoplasm of upper third of esophagus 150.4 Malignant neoplasm of middle third of esophagus C15.4 Malignant neoplasm of middle third of esophagus 150.5 Malignant neoplasm of lower third of esophagus C15.5 Malignant neoplasm of lower third of esophagus 150.9 Malignant neoplasm of esophagus, unspecified C15.9 Malignant neoplasm of esophagus, unspecified site 151.0 Malignant neoplasm of cardia C16.0 Malignant neoplasm of cardia 151.9 Malignant neoplasm of stomach, unspecified site C16.9 Malignant neoplasm of stomach, unspecified 162.0 Malignant neoplasm of trachea C33 Malignant neoplasm of trachea 162.2 Malignant neoplasm of main bronchus C34.00 Malignant neoplasm of unspecified main bronchus 162.2 Malignant neoplasm of main bronchus C34.01 Malignant neoplasm of right main bronchus 162.2 Malignant neoplasm of main bronchus C34.02 Malignant neoplasm of left main bronchus 162.3 Malignant neoplasm of upper lobe, bronchus or C34.10 Malignant neoplasm of upper lobe, unspecified lung bronchus or lung 162.3 Malignant neoplasm of upper lobe, bronchus or C34.11 Malignant neoplasm of upper lobe, right bronchus lung or lung 162.3 Malignant neoplasm of upper lobe, bronchus or C34.12 Malignant neoplasm of upper lobe, left bronchus lung or lung 162.4 Malignant neoplasm of middle lobe, bronchus or C34.2 Malignant neoplasm of middle lobe, bronchus or lung lung 162.5 Malignant neoplasm of lower lobe, bronchus or C34.30 Malignant neoplasm of lower lobe, unspecified lung bronchus or lung 162.5 Malignant neoplasm of lower lobe, bronchus or C34.31 Malignant neoplasm of lower lobe, right bronchus lung or lung 162.5 Malignant neoplasm of lower lobe, bronchus or C34.32 Malignant neoplasm of lower lobe, left bronchus lung or lung 162.8 Malignant neoplasm of other parts of bronchus or C34.80 Malignant neoplasm of overlapping sites of lung unspecified bronchus and lung 162.8 Malignant neoplasm of other parts of bronchus or C34.81 Malignant neoplasm of overlapping sites of right lung bronchus and lung Page 1 of 11 8-2015 General Thoracic Surgery ICD9 to ICD10 Crosswalks 162.8 Malignant neoplasm of other parts of bronchus or C34.82 Malignant neoplasm of overlapping sites of left lung bronchus and lung 162.9 Malignant neoplasm of bronchus and lung, C34.90 Malignant neoplasm of unspecified part of unspecified unspecified bronchus or lung 162.9 Malignant neoplasm of bronchus and lung, C34.91 Malignant neoplasm of unspecified part of right unspecified bronchus or lung 162.9 Malignant neoplasm of bronchus and lung, C34.92 Malignant neoplasm of unspecified part of left unspecified bronchus or lung 163.9 Malignant neoplasm of pleura, unspecified C38.4 Malignant neoplasm of pleura 163.9 Malignant neoplasm of pleura, unspecified C45.0 Mesothelioma of pleura 164.0 Malignant neoplasm of thymus C37 Malignant neoplasm of thymus 164.2 Malignant neoplasm of anterior mediastinum C38.1 Malignant neoplasm of anterior mediastinum 164.3 Malignant neoplasm of posterior mediastinum C38.2 Malignant neoplasm of posterior mediastinum 170.3 Malignant neoplasm of ribs, sternum, and clavicle C41.3 Malignant neoplasm of ribs, sternum and clavicle 171.4 Malignant neoplasm of connective and other soft C49.3 Malignant neoplasm of connective and soft tissue tissue of thorax of thorax 193 Malignant neoplasm of thyroid gland C73 Malignant neoplasm of thyroid gland 196.1 Secondary and unspecified malignant neoplasm C77.1 Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes of intrathoracic lymph nodes 197.0 Secondary malignant neoplasm of lung C78.00 Secondary malignant neoplasm of unspecified lung 197.0 Secondary malignant neoplasm of lung C78.01 Secondary malignant neoplasm of right lung 197.0 Secondary malignant neoplasm of lung C78.02 Secondary malignant neoplasm of left lung 197.1 Secondary malignant neoplasm of mediastinum C78.1 Secondary malignant neoplasm of mediastinum 197.2 Secondary malignant neoplasm of pleura C78.2 Secondary malignant neoplasm of pleura 197.3 Secondary malignant neoplasm of other C78.30 Secondary malignant neoplasm of unspecified respiratory organs respiratory organ 197.3 Secondary malignant neoplasm of other C78.39 Secondary malignant neoplasm of other respiratory organs respiratory organs 198.5 Secondary malignant neoplasm of bone and bone C79.51 Secondary malignant neoplasm of bone marrow Page 2 of 11 8-2015 General Thoracic Surgery ICD9 to ICD10 Crosswalks 198.5 Secondary malignant neoplasm of bone and bone C79.52 Secondary malignant neoplasm of bone marrow marrow 198.89 Secondary malignant neoplasm of other specified C79.89 Secondary malignant neoplasm of other specified sites sites 198.89 Secondary malignant neoplasm of other specified C79.9 Secondary malignant neoplasm of unspecified sites site 202.82 Other malignant lymphomas, intrathoracic lymph C82.52 Diffuse follicle center lymphoma, intrathoracic nodes lymph nodes 202.82 Other malignant lymphomas, intrathoracic lymph C84.92 Mature T/NK-cell lymphomas, unspecified, nodes intrathoracic lymph nodes 202.82 Other malignant lymphomas, intrathoracic lymph C84.A2 Cutaneous T-cell lymphoma, unspecified, nodes intrathoracic lymph nodes 202.82 Other malignant lymphomas, intrathoracic lymph C84.Z2 Other mature T/NK-cell lymphomas, intrathoracic nodes lymph nodes 202.82 Other malignant lymphomas, intrathoracic lymph C85.12 Unspecified B-cell lymphoma, intrathoracic lymph nodes nodes 202.82 Other malignant lymphomas, intrathoracic lymph C85.22 Mediastinal (thymic) large B-cell lymphoma, nodes intrathoracic lymph nodes 202.82 Other malignant lymphomas, intrathoracic lymph C85.82 Other specified types of non-Hodgkin lymphoma, nodes intrathoracic lymph nodes 202.82 Other malignant lymphomas, intrathoracic lymph C85.92 Non-Hodgkin lymphoma, unspecified, nodes intrathoracic lymph nodes 209.21 Malignant carcinoid tumor of the bronchus and C7A.090 Malignant carcinoid tumor of the bronchus and lung lung 211.0 Benign neoplasm of esophagus D13.0 Benign neoplasm of esophagus 212.2 Benign neoplasm of trachea D14.2 Benign neoplasm of trachea 212.3 Benign neoplasm of bronchus and lung D14.30 Benign neoplasm of unspecified bronchus and lung 212.3 Benign neoplasm of bronchus and lung D14.31 Benign neoplasm of right bronchus and lung 212.3 Benign neoplasm of bronchus and lung D14.32 Benign neoplasm of left bronchus and lung 212.4 Benign neoplasm of pleura D19.0 Benign neoplasm of mesothelial tissue of pleura 212.5 Benign neoplasm of mediastinum D15.2 Benign neoplasm of mediastinum Page 3 of 11 8-2015 General Thoracic Surgery ICD9 to ICD10 Crosswalks 212.5 Benign neoplasm of mediastinum D15.2 Benign neoplasm of mediastinum 212.6 Benign neoplasm of thymus D15.0 Benign neoplasm of thymus 213.3 Benign neoplasm of ribs, sternum, and clavicle D16.7 Benign neoplasm of ribs, sternum and clavicle 215.4 Other benign neoplasm of connective and other D21.3 Benign neoplasm of connective and other soft soft tissue of thorax tissue of thorax 226 Benign neoplasm of thyroid glands D34 Benign neoplasm of thyroid gland 229.0 Benign neoplasm of lymph nodes D36.0 Benign neoplasm of lymph nodes 235.7 Neoplasm of uncertain behavior of trachea, D38.1 Neoplasm of uncertain behavior of trachea, bronchus, and lung bronchus and lung 235.8 Neoplasm of uncertain behavior of pleura, D38.2 Neoplasm of uncertain behavior of pleura thymus, and mediastinum 235.8 Neoplasm of uncertain behavior of pleura, D38.3 Neoplasm of uncertain behavior of mediastinum thymus, and mediastinum 235.8 Neoplasm of uncertain behavior of pleura, D38.4 Neoplasm of uncertain behavior of thymus thymus, and mediastinum 241.9 Unspecified nontoxic nodular goiter E04.8 Other specified nontoxic goiter 241.9 Unspecified nontoxic nodular goiter E04.9 Nontoxic goiter, unspecified 254.0 Persistent hyperplasia of thymus E32.0 Persistent hyperplasia of thymus 254.1 Abscess of thymus E32.1 Abscess of thymus 254.8 Other specified diseases of thymus gland E32.8 Other diseases of thymus 254.9 Unspecified disease of thymus gland E32.9 Disease of thymus, unspecified 277.02 Cystic fibrosis with pulmonary manifestations E84.0 Cystic fibrosis with pulmonary manifestations 353.0 Brachial plexus lesions G54.0 Brachial plexus disorders 358.00 Myasthenia gravis without (acute) exacerbation G70.00 Myasthenia gravis without (acute) exacerbation 358.01 Myasthenia gravis with (acute) exacerbation G70.01 Myasthenia gravis with (acute) exacerbation 416.0 Primary pulmonary hypertension I27.0 Primary pulmonary hypertension 457.8 Other noninfectious disorders of lymphatic I89.8 Other specified noninfective disorders of channels lymphatic vessels and lymph nodes 478.31 Unilateral paralysis of vocal cords or larynx, J38.01 Paralysis of vocal cords and larynx, unilateral partial 478.33 Bilateral paralysis of vocal cords or larynx, partial J38.02 Paralysis of vocal cords and larynx, bilateral 478.74 Stenosis of larynx J38.6 Stenosis of larynx Page 4 of 11 8-2015 General Thoracic Surgery ICD9 to ICD10 Crosswalks 486 Pneumonia, organism unspecified J18.8 Other pneumonia, unspecified organism 486 Pneumonia, organism unspecified J18.9 Pneumonia, unspecified organism 492.0 Emphysematous bleb J43.9 Emphysema, unspecified 492.8 Other emphysema J43.0 Unilateral pulmonary emphysema [MacLeod's syndrome] 492.8 Other emphysema J43.1 Panlobular emphysema 492.8 Other emphysema J43.2 Centrilobular emphysema 492.8 Other emphysema J43.8 Other
Load more

Recommended publications
  • 1 British Thoracic Society Guidelines Recommendations for The
    Thorax Online First, published on September 28, 2007 as 10.1136/thx.2007.077370 Thorax: first published as 10.1136/thx.2007.077370 on 28 September 2007. Downloaded from British Thoracic Society Guidelines Recommendations for the assessment and management of cough in children MD Shields, A Bush, ML Everard, S McKenzie and R Primhak on behalf of the British Thoracic Society Cough Guideline Group Michael D Shields Dept. of Child Health, Queen’s University of Belfast, Clinical Institute, Grosvenor Road, Belfast, BT12 6BJ Email: [email protected] Andrew Bush Royal Brompton Hospital, Sydney Street, London, SW3 6NP Email: [email protected] Mark L Everard Dept of Paediatrics, Sheffield Children’s Hospital, Western Bank, Sheffield, S. Yorkshire, S10 2TH. Email: [email protected] Sheila McKenzie Queen Elizabeth Children’s Services, http://thorax.bmj.com/ The Royal London Hospital, Whitechapel, London, E1 1BB Email: [email protected] Robert Primhak Dept. of Paediatrics, Sheffield Children’s Hospital, on September 29, 2021 by guest. Protected copyright. Western Bank, Sheffield, S. Yorkshire, S10 2TH. Email: [email protected] “the Corresponding Author (Michael D Shields) has the right to grant on behalf of all authors and does grant on behalf of all authors, an exclusive licence (or non exclusive for government employees) on a worldwide basis to the BMJ Publishing Group Ltd and its Licensees to permit this article (if accepted) to be published in [THORAX] editions and any other BMJPG Ltd products to exploit all subsidiary rights, as set out in our licence 1 Copyright Article author (or their employer) 2007.
    [Show full text]
  • Complications of Different Ventilation Strategies in Endoscopic Laryngeal
    Anesthesiology 2006; 104:52–9 © 2005 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Complications of Different Ventilation Strategies in Endoscopic Laryngeal Surgery A 10-year Review Yves Jaquet, M.D.,* Philippe Monnier, M.D.,† Guy Van Melle, M.D., Ph.D.,‡ Patrick Ravussin, M.D.,§ Donat R. Spahn, M.D., F.R.C.A.,࿣ Madeleine Chollet-Rivier, M.D.# Background: Spontaneous ventilation, mechanical controlled tracheal tube offers adequate airway protection and ventilation, apneic intermittent ventilation, and jet ventilation gas exchange, but the endotracheal tube prevents are commonly used during interventional suspension micro- optimal vision and access to the larynx. Furthermore, laryngoscopy. The aim of this study was to investigate specific 1–4 complications of each technique, with special emphasis on endotracheal fire may still be encountered with transtracheal and transglottal jet ventilation. the use of carbon dioxide laser despite the develop- Methods: The authors performed a retrospective single-insti- ment of nonflammable endotracheal tubes.5–7 tution analysis of a case series of 1,093 microlaryngoscopies 2. Spontaneous ventilation offers a free access to the performed in 661 patients between January 1994 and January larynx, but with a moving surgical field and a risk of 2004. Data were collected from two separate prospective data- bases. Feasibility and complications encountered with each inhalation of anesthetic gases and laser fumes by the technique of ventilation were analyzed as main outcome mea- patient
    [Show full text]
  • Diagnosis and Therapy for Airway Obstruction in Children with Down Syndrome
    ORIGINAL ARTICLE Diagnosis and Therapy for Airway Obstruction in Children With Down Syndrome Ron B. Mitchell, MD; Ellen Call, MS, CFNP; James Kelly, PhD Objectives: To document the causes of upper airway children had subglottic stenosis. Laryngomalacia was the obstruction in a population of children with Down syn- primary diagnosis in 10 children (43%), 8 of whom were drome and to highlight the role of associated comorbidi- younger than 1 month. Obstructive sleep apnea was the ties. primary diagnosis in 11 children (48%), 8 of whom were older than 2 years. All children with obstructive sleep ap- Design and Setting: Review of 23 cases involving chil- nea and 4 children with laryngomalacia had a second- dren with Down syndrome who were referred for upper ary ear, nose, and throat disorder. Gastroesophageal re- airway obstruction over a 21⁄2-year period to the Pediat- flux was a comorbidity in 14 children (61%). ric Otolaryngology Service of the University of New Mexico, Albuquerque. Conclusions: The causes, severity, and presentation of upper airway obstruction in children with Down syn- Methods: Data on the following variables were ob- drome are related to the age of the child and to associ- tained: reason for referral, demographics, diagnosis, sur- ated comorbidities. The treatment of comorbidities and gical procedures, complications, and comorbidities. secondary ear, nose, and throat disorders is an integral component of the surgical management of upper airway Results: The children ranged in age from 1 day to 10.2 obstruction in such cases. years (mean age, 1.8 years; median age, 6 months). Thir- teen children were male and 10 were female.
    [Show full text]
  • The Diseases of Airway-Tracheal Diverticulum: a Review of the Literature
    Review Article The diseases of airway-tracheal diverticulum: a review of the literature Asli Tanrivermis Sayit, Muzaffer Elmali, Dilek Saglam, Cetin Celenk Department of Radiology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey Contributions: (I) Conception and design: A Tanrivermis Sayit; (II) Administrative support: M Elmali, C Celenk; (III) Provision of study materials or patients: A Tanrivermis Sayit; (IV) Collection and assembly of data: A Tanrivermis Sayit, D Saglam; (V) Data analysis and interpretation: A Tanrivermis Sayit, M Elmali, C Celenk; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Asli Tanrivermis Sayit. Department of Radiology, Faculty of Medicine, Ondokuz Mayis University, 55139, Atakum/Samsun, Turkey. Email: [email protected]. Abstract: Tracheal diverticulum (DV) is a type of paratracheal air cyst (PTAC) that is often asymptomatic and usually detected incidentally by imaging methods. Tracheal DV are divided into two subgroups: congenital and acquired. Dysphagia, odynophagia, neck pain, hoarseness, hemoptysis, choking, and recurrent episodes of hiccups and burping can also be seen in symptomatic patients. Thin-section multidetector computed tomography (MDCT) is useful for diagnosis of tracheal diverticulum. The relationship between DV and tracheal lumen can be demonstrated by axial, coronal, and sagittal reformat multiplanar images. Bronchoscopy can also be used in diagnosis for tracheal DV. However, the connection between DV and tracheal lumen can not be shown easily with bronchoscopy. Conservative treatment is the preferred treatment in asymptomatic patients. Surgical or conservative treatment can be performed for symptomatic patients, depending on patient age and physical condition. Keywords: Trachea; diverticulum (DV); thorax; multidetector computed tomography; tracheal diseases; chronic obstructive pulmonary disease (CODP) Submitted Sep 17, 2016.
    [Show full text]
  • PQI 15 Asthma in Younger Adults Admission Rate
    AHRQ Quality Indicators™ (AHRQ QI™) ICD-10-CM/PCS Specification v2021 Prevention Quality Indicator 15 (PQI 15) Asthma in Younger Adults Admission Rate July 2021 Area-Level Indicator Type of Score: Rate Prepared by: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services www.qualityindicators.ahrq.gov DESCRIPTION Admissions for a principal diagnosis of asthma per 100,000 population, ages 18 to 39 years. Excludes admissions with an indication of cystic fibrosis or anomalies of the respiratory system, obstetric admissions, and transfers from other institutions. [NOTE: The software provides the rate per population. However, common practice reports the measure as per 100,000 population. The user must multiply the rate obtained from the software by 100,000 to report admissions per 100,000 population.] NUMERATOR Discharges, for patients ages 18 through 39 years, with a principal ICD-10-CM diagnosis code for asthma (ACSASTD*). [NOTE: Obstetric discharges are not included in the PQI rate for PQI 15, though the AHRQ QI™ does not explicitly exclude obstetric cases. By definition, discharges with a principal diagnosis of asthma exclude obstetric discharges, because the principal diagnosis for an obstetric discharge would identify it as obstetric, and no such diagnoses are included in the set of qualifying diagnoses.] July 2021 1 of 5 AHRQ QI™ ICD-10-CM/PCS Specification v2021 PQI 15 Asthma in Younger Adults Admission Rate www.qualityindicators.ahrq.gov NUMERATOR EXCLUSIONS Exclude cases: • with any listed ICD-10-CM
    [Show full text]
  • Supraglottoplasty Home Care Instructions Hospital Stay Most Children Stay Overnight in the Hospital for at Least One Night
    10914 Hefner Pointe Drive, Suite 200 Oklahoma City, OK 73120 Phone: 405.608.8833 Fax: 405.608.8818 Supraglottoplasty Home Care Instructions Hospital Stay Most children stay overnight in the hospital for at least one night. Bleeding There is typically very little to no bleeding associated with this procedure. Though very unlikely to happen, if your child were to spit or cough up blood you should contact your physician immediately. Diet After surgery your child will be able to eat the foods or formula that they usually do. It is important after surgery to encourage your child to drink fluids and remain hydrated. Daily fluid needs are listed below: • Age 0-2 years: 16 ounces per day • Age 2-4 years: 24 ounces per day • Age 4 and older: 32 ounces per day It is our experience that most children experience a significant improvement in eating after this procedure. However, we have found about that approximately 4% of otherwise healthy infants may experience a transient onset of coughing or choking with feeding after surgery. In our experience these symptoms resolve over 1-2 months after surgery. We have also found that infants who have other illnesses (such as syndromes, prematurity, heart trouble, or other congenital abnormalities) have a greater risk of experiencing swallowing difficulties after a supraglottoplasty (this number can be as high as 20%). In time the child usually will return to normal swallowing but there is a small risk of feeding difficulties. You will be given a prescription before you leave the hospital for an acid reducing (anti-reflux) medication that must be filled before you are discharged.
    [Show full text]
  • Prioritization of Health Services
    PRIORITIZATION OF HEALTH SERVICES A Report to the Governor and the 74th Oregon Legislative Assembly Oregon Health Services Commission Office for Oregon Health Policy and Research Department of Administrative Services 2007 TABLE OF CONTENTS List of Figures . iii Health Services Commission and Staff . .v Acknowledgments . .vii Executive Summary . ix CHAPTER ONE: A HISTORY OF HEALTH SERVICES PRIORITIZATION UNDER THE OREGON HEALTH PLAN Enabling Legislatiion . 3 Early Prioritization Efforts . 3 Gaining Waiver Approval . 5 Impact . 6 CHAPTER TWO: PRIORITIZATION OF HEALTH SERVICES FOR 2008-09 Charge to the Health Services Commission . .. 25 Biennial Review of the Prioritized List . 26 A New Prioritization Methodology . 26 Public Input . 36 Next Steps . 36 Interim Modifications to the Prioritized List . 37 Technical Changes . 38 Advancements in Medical Technology . .42 CHAPTER THREE: CLARIFICATIONS TO THE PRIORITIZED LIST OF HEALTH SERVICES Practice Guidelines . 47 Age-Related Macular Degeneration (AMD) . 47 Chronic Anal Fissure . 48 Comfort Care . 48 Complicated Hernias . 49 Diagnostic Services Not Appearing on the Prioritized List . 49 Non-Prenatal Genetic Testing . 49 Tuberculosis Blood Test . 51 Early Childhood Mental Health . 52 Adjustment Reactions In Early Childhood . 52 Attention Deficit and Hyperactivity Disorders in Early Childhood . 53 Disruptive Behavior Disorders In Early Childhood . 54 Mental Health Problems In Early Childhood Related To Neglect Or Abuse . 54 Mood Disorders in Early Childhood . 55 Erythropoietin . 55 Mastocytosis . 56 Obesity . 56 Bariatric Surgery . 56 Non-Surgical Management of Obesity . 58 PET Scans . 58 Prenatal Screening for Down Syndrome . 59 Prophylactic Breast Removal . 59 Psoriasis . 59 Reabilitative Therapies . 60 i TABLE OF CONTENTS (Cont’d) CHAPTER THREE: CLARIFICATIONS TO THE PRIORITIZED LIST OF HEALTH SERVICES (CONT’D) Practice Guidelines (Cont’d) Sinus Surgery .
    [Show full text]
  • Stridor in the Newborn
    Stridor in the Newborn Andrew E. Bluher, MD, David H. Darrow, MD, DDS* KEYWORDS Stridor Newborn Neonate Neonatal Laryngomalacia Larynx Trachea KEY POINTS Stridor originates from laryngeal subsites (supraglottis, glottis, subglottis) or the trachea; a snoring sound originating from the pharynx is more appropriately considered stertor. Stridor is characterized by its volume, pitch, presence on inspiration or expiration, and severity with change in state (awake vs asleep) and position (prone vs supine). Laryngomalacia is the most common cause of neonatal stridor, and most cases can be managed conservatively provided the diagnosis is made with certainty. Premature babies, especially those with a history of intubation, are at risk for subglottic pathologic condition, Changes in voice associated with stridor suggest glottic pathologic condition and a need for otolaryngology referral. INTRODUCTION Families and practitioners alike may understandably be alarmed by stridor occurring in a newborn. An understanding of the presentation and differential diagnosis of neonatal stridor is vital in determining whether to manage the child with further observation in the primary care setting, specialist referral, or urgent inpatient care. In most cases, the management of neonatal stridor is outside the purview of the pediatric primary care provider. The goal of this review is not, therefore, to present an exhaustive review of causes of neonatal stridor, but rather to provide an approach to the stridulous newborn that can be used effectively in the assessment and triage of such patients. Definitions The neonatal period is defined by the World Health Organization as the first 28 days of age. For the purposes of this discussion, the newborn period includes the first 3 months of age.
    [Show full text]
  • Practice Parameter for the Diagnosis and Management of Primary Immunodeficiency
    Practice parameter Practice parameter for the diagnosis and management of primary immunodeficiency Francisco A. Bonilla, MD, PhD, David A. Khan, MD, Zuhair K. Ballas, MD, Javier Chinen, MD, PhD, Michael M. Frank, MD, Joyce T. Hsu, MD, Michael Keller, MD, Lisa J. Kobrynski, MD, Hirsh D. Komarow, MD, Bruce Mazer, MD, Robert P. Nelson, Jr, MD, Jordan S. Orange, MD, PhD, John M. Routes, MD, William T. Shearer, MD, PhD, Ricardo U. Sorensen, MD, James W. Verbsky, MD, PhD, David I. Bernstein, MD, Joann Blessing-Moore, MD, David Lang, MD, Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher R. Randolph, MD, Diane Schuller, MD, Sheldon L. Spector, MD, Stephen Tilles, MD, Dana Wallace, MD Chief Editor: Francisco A. Bonilla, MD, PhD Co-Editor: David A. Khan, MD Members of the Joint Task Force on Practice Parameters: David I. Bernstein, MD, Joann Blessing-Moore, MD, David Khan, MD, David Lang, MD, Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher R. Randolph, MD, Diane Schuller, MD, Sheldon L. Spector, MD, Stephen Tilles, MD, Dana Wallace, MD Primary Immunodeficiency Workgroup: Chairman: Francisco A. Bonilla, MD, PhD Members: Zuhair K. Ballas, MD, Javier Chinen, MD, PhD, Michael M. Frank, MD, Joyce T. Hsu, MD, Michael Keller, MD, Lisa J. Kobrynski, MD, Hirsh D. Komarow, MD, Bruce Mazer, MD, Robert P. Nelson, Jr, MD, Jordan S. Orange, MD, PhD, John M. Routes, MD, William T. Shearer, MD, PhD, Ricardo U. Sorensen, MD, James W. Verbsky, MD, PhD GlaxoSmithKline, Merck, and Aerocrine; has received payment for lectures from Genentech/ These parameters were developed by the Joint Task Force on Practice Parameters, representing Novartis, GlaxoSmithKline, and Merck; and has received research support from Genentech/ the American Academy of Allergy, Asthma & Immunology; the American College of Novartis and Merck.
    [Show full text]
  • Laryngomalacia: Disease Presentation, Spectrum, and Management
    Hindawi Publishing Corporation International Journal of Pediatrics Volume 2012, Article ID 753526, 6 pages doi:10.1155/2012/753526 Review Article Laryngomalacia: Disease Presentation, Spectrum, and Management April M. Landry1 and Dana M. Thompson2 1 Department of Otolaryngology, Head and Neck Surgery, Mayo Clinic Arizona, Phoenix, AZ 85054, USA 2 Division of Pediatric Otolaryngology, Department of Otorhinolaryngology, Head and Neck Surgery, Mayo Clinic Children’s Center and Mayo Eugenio Litta Children’s Hospital, Mayo Clinic Rochester, 200 First Street SW, Gonda 12, Rochester, MN 55905, USA Correspondence should be addressed to Dana M. Thompson, [email protected] Received 10 August 2011; Accepted 23 November 2011 Academic Editor: Jeffrey A. Koempel Copyright © 2012 A. M. Landry and D. M. Thompson. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Laryngomalacia is the most common cause of stridor in newborns, affecting 45–75% of all infants with congenital stridor. The spectrum of disease presentation, progression, and outcomes is varied. Identifying symptoms and patient factors that influence disease severity helps predict outcomes. Findings. Infants with stridor who do not have significant feeding-related symptoms can be managed expectantly without intervention. Infants with stridor and feeding-related symptoms benefit from acid suppression treatment. Those with additional symptoms of aspiration, failure to thrive, and consequences of airway obstruction and hypoxia require surgical intervention. The presence of an additional level of airway obstruction worsens symptoms and has a 4.5x risk of requiring surgical intervention, usually supraglottoplasty.
    [Show full text]
  • Series of Laryngomalacia, Tracheomalacia, and Bronchomalacia Disorders and Their Associations with Other Conditions in Children
    Pediatric Pulmonology 34:189-195 (2002) Series of Laryngomalacia, Tracheomalacia, and Bronchomalacia Disorders and Their Associations With Other Conditions in Children I.B. Masters, MBBS, FRACP,1* A.B. Chang, PhD, FRACP,2 L. Patterson, MBBS, FANZCAC,1 С Wainwright, MD, FRACP,1 H. Buntain, MBBS,1 B.W. Dean, MSC,1 and P.W. Francis, MD, FRACP1 Summary. Laryngomalacia, bronchomalacia, and tracheomalacia are commonly seen in pediatric respiratory medicine, yet their patterns and associations with other conditions are not well-understood. We prospectively video-recorded bronchoscopic data and clinical information from referred patients over a 10-year period and defined aspects of interrelationships and associations. Two hundred and ninety-nine cases of malacia disorders (34%) were observed in 885 bronchoscopic procedures. Cough, wheeze, stridor, and radiological changes were the most common symptoms and signs. The lesions were most often found in males (2:1) and on the left side (1.6:1). Concomitant malacia lesions ranged from 24%forlaryngotracheobronchomalaciato 47% for tracheobronchomalacia. The lesions were found in association with other disorders such as congenital heart disorders (13.7%), tracheo-esophageal fistula (9.6%), and various syndromes (8%). Even though the understanding of these disorders is in its infancy, pediatricians should maintain a level of awareness for malacia lesions and consider the possibility of multiple lesions being present, even when one symptom predominates or occurs alone. Pediatr Pulmonol Pediatr Pulmonol. 2002; 34:189-195. © 2002 wiiey-Liss. inc. Key words: laryngomalacia; tracheomalacia; bronchomalacia; malacia disorders; syndromes. INTRODUCTION The aim of this report is to describe an extensive experience of various forms of laryngomalacia, tracheo­ Tracheomalacia, bronchomalacia, and laryngomalacia malacia, and bronchomalacia and explore some of the disorders are commonly seen in tertiary pediatric respira­ interrelationships that exist between these conditions with tory practice.
    [Show full text]
  • Obstructive Sleep Apnea Diagnosis and Treatment
    Obstructive Sleep Apnea Diagnosis and Treatment Last Review Date: February 12, 2021 Number: MG.MM.ME.25qv2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth the clinical evidence that the patient meets the criteria for the treatment or surgical procedure. Without this documentation and information, EmblemHealth will not be able to properly review the request for prior authorization. The clinical review criteria expressed below reflects how EmblemHealth determines whether certain services or supplies are medically necessary. EmblemHealth established the clinical review criteria based upon a review of currently available clinical information (including clinical outcome studies in the peer reviewed published medical literature, regulatory status of the technology, evidence-based guidelines of public health and health research agencies, evidence-based guidelines and positions of leading national health professional organizations, views of physicians practicing in relevant clinical areas, and other relevant factors). EmblemHealth expressly reserves the right to revise these conclusions as clinical information changes and welcomes further relevant information. Each benefit program defines which services are covered. The conclusion that a particular service or supply is medically necessary does not constitute a representation or warranty that this service or supply is covered and/or paid for by EmblemHealth, as some programs exclude coverage for services or supplies that EmblemHealth considers medically necessary. If there is a discrepancy between this guideline and a member's benefits program, the benefits program will govern. In addition, coverage may be mandated by applicable legal requirements of a state, the Federal Government or the Centers for Medicare & Medicaid Services (CMS) for Medicare and Medicaid members.
    [Show full text]